Toral Patel Selected Research

Neoplasms (Cancer)

1/2022	EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.
2/2011	Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toral Patel Research Topics

Disease

4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2011
2	Neoplasms (Cancer) 01/2022 - 02/2011
2	Hemorrhage 01/2019 - 07/2013
1	Neoplasm Metastasis (Metastasis) 04/2024
1	Thrombophilia 05/2023
1	Protein S Deficiency (Deficiency, Protein S) 05/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2023
1	Thrombosis (Thrombus) 05/2023
1	Lymphoma (Lymphomas) 05/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Glioma (Gliomas) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Stroke (Strokes) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	ST Elevation Myocardial Infarction 01/2019
1	Myocardial Infarction 01/2019
1	Cardiogenic Shock 01/2019
1	Pharyngitis (Sore Throat) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Hypertension (High Blood Pressure) 12/2016
1	Pneumonia (Pneumonitis) 06/2014
1	False Aneurysm (Pseudoaneurysm) 07/2013
1	Gliosarcoma 02/2011
1	Cerebrospinal Fluid Rhinorrhea 01/2010
1	Diarrhea 12/2009
1	Clostridium Infections 12/2009
1	Rheumatoid Arthritis 01/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2004

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
1	RheniumIBA 04/2024
1	Warfarin (Coumadin)FDA LinkGeneric 05/2023
1	Protein SIBA 05/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 05/2023
1	AnticoagulantsIBA 05/2023
1	apixabanIBA 05/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	LigandsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2021
1	EnzymesIBA 01/2021
1	Large Neutral Amino Acid-Transporter 1IBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AcidsIBA 01/2020
1	AntigensIBA 01/2017
1	alpha-hydroxyglutarateIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 12/2016
1	EDP 420IBA 06/2014
1	Indicators and Reagents (Reagents)IBA 07/2013
1	PolymersIBA 02/2011
1	CamptothecinIBA 02/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2011
1	Vancomycin FDA LinkGeneric 12/2009
1	Dexfenfluramine (Redux)IBA 12/2009
1	Rifaximin (L 105)FDA Link 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004
1	CytokinesIBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	Adalimumab (Humira)FDA Link 01/2004

Therapy/Procedure

4	Therapeutics 05/2022 - 01/2004
2	Transcatheter Aortic Valve Replacement 05/2023 - 01/2019
1	General Anesthesia 01/2019
1	Percutaneous Coronary Intervention 01/2019
1	Decompression 01/2019
1	Conscious Sedation 01/2019
1	Extracorporeal Membrane Oxygenation 01/2019
1	Drug Therapy (Chemotherapy) 02/2011
1	Splints (Splint) 01/2010
1	Subcutaneous Injections 01/2004
1	Biological Therapy 01/2004